Co-chairs

I, Bella A. Maranion, residing in the United States and appointed as a co-chair of the Technology and Economic Assessment Panel (TEAP), co-chair of Decision XXXI-1 TEAP Task Force on Replenishment of the Multilateral Fund, and member of the Decision XXXI-3 TEAP Task Force on CFC-11 declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a full-time employee of the United States Environmental Protection Agency’s (USEPA) Stratospheric Protection Division, Washington, DC. My responsibilities include working as Branch Chief of the Alternatives and Emissions Reduction Branch, Stratospheric Protection Division, and sector analyst in a program that includes reviews of alternatives for various sectors of use in support of the U.S. transition away from ozone-depleting substances (ODS). In this capacity, I work within the various sectors of ODS including the fire suppression sector to review the human health and environmental effects of alternatives to ozone-depleting halons, once widely used in many specialty industrial, military, marine, and aviation applications. I serve as member on a number of technical committees under the International Organization for Standardization (ISO), International Civil Aviation Organization (ICAO), and the National Fire Protection Association (NFPA). I also work on issues such as recovery/recycling and destruction of ODS with related government and nongovernmental organizations and stakeholders in the U.S. The USEPA has an interest in the topics of the Montreal Protocol because the Agency is responsible for implementing national regulations and policies to meet the US commitments under the Protocol. In addition, the USEPA has funded government and non-governmental organizations working on ozone layer protection, atmospheric science, and environmental and health effects research.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents, include the following:
   1. Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or this task force.
   2. Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   3. Employment, consultancy, directorship or other positions: I am not currently employed, consulting, or hold any other position in any entity which has an interest in the subject matter of this task force.
   4. Government advice and other policy development: My responsibilities at the USEPA may include providing information and advice to stakeholders on the interpretation and compliance with national regulations to protect the ozone layer and related to the transition away from ODS in the U.S. I do not provide advice on significant issues to a government with respect to its implementation of the Montreal Protocol or engage in the development of significant policy positions of a government for a Montreal Protocol meeting.
   5. Paid research activities, fellowships or grants: I am not performing any paid research activities or receive any fellowships or grants for work related to a proposed use of an ODS or an alternative to a proposed use of an ODS.
   6. Other interests: I do not have other interests related to the subject matter of this task force.
5. The source of funding for my participation in the work of the TEAP is USEPA.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines. 
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: Bella A. Maranion
Date: 20 January 2020

I, Marta Pizano, nominated by Colombia and residing in Bogotá, Colombia, have been re-nominated by the Parties to the Montreal Protocol as co-chair of MBTOC until 31st December 2021 and co-chair of TEAP until 31st December 2022. I declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. My responsibilities include

1. I am an independent consultant often working for the Montreal Protocol Implementing Agencies involved with methyl bromide users and other key stakeholders in many countries, to identify and implement alternatives to methyl bromide, including research on QPS uses and their alternatives. I also consult for the agencies on other topics related to ODS and the Montreal Protocol, for example the sustainability of the phase-out achieved for different ODS, clarification on exempted uses, communication materials to raise awareness on various issues relating to the Protocol and others. This works includes the United Nations Industrial Development Organization (UNIDO), United Nations Development Programme (UNDP), the United Nations Environment Programme (UNE, and its OzonAction Programme) and the World Bank (WB). I have also assisted the Montreal Protocol Multilateral Fund (MLF) with monitoring and evaluation work. All such work is been conducted on a short-term assignment basis, as an external consultant.
2. Neither myself nor my husband (an orthopaedic surgeon) nor our children own stock or have proprietary interest in companies producing ODS or their alternatives or substitutes.
3. I also consult for floriculture and horticulture trade associations, Government programmes and agencies (i.e. USAID, International Trade Centre ITC, Netherlands CBI) particularly on improving trade competitiveness and sustainable production issues in Latin America and Africa.
4. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
5. My interests and those of my husband or children include the following
   • Proprietary interests: [None related to ODS or their alternatives)
   • Financial interests: [None related to ODS or their alternatives]
   • Employment, consultancy, directorship or other positions: [Consultancy for implementing agencies of the Protocol and the MLF as described in numeral 2 above]
   • Government advice and other policy development: [None]
   • Paid research activities, fellowships or grants: [None]
   • Other interests: [None]
6. As an A5 member my travel and accommodation to attend Montreal Protocol, TEAP and MBTOC meetings are funded by UNEP’s Ozone Secretariat. In addition, as co-chair of the TEAP and MBTOC, I receive some funding support from the Ozone Secretariat for administrative tasks related to the work of the TEAP and MBTOC. As a consultant who is self-employed, I conduct other work related to the Panel and MBTOC on a voluntary (unpaid) basis.
7. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines. 
8. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
9. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP and the MBTOC.
10. I understand that this DOI will expire no later than one year after I have signed it.

Signed: Marta Pizano
Date: January 29, 2020

I, Ashley Woodcock, residing in United Kingdom, nominated to TEAP by United Kingdom declare as follows.

1) I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.

2) I am a Consultant Respiratory Physician and Professor of Respiratory Medicine.

3) This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.

4) My interests, and those of my personal partner and dependents include the following:  I am a member of the NW Lung Centre Charity and Chairman of its subsidiary Medicines Evaluation Unit. I am Chairman of Axalbion which is developing a new oral cough medicine (in Phase 1). I am Chairman of Reacta which is developing diagnostic tests for Food Allergy. None of these have any interest in relation to the Montreal Protocol, TEAP, MCTOC, or its Task Forces.

• Proprietary interests: I do not have proprietary interest in the subject matter of the Montreal Protocol, TEAP, MCTOC, or any Task Force.
• Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the Montreal Protocol, TEAP, MCTOC, or any Task Force.
• Employment, consultancy, directorship or other positions:  I occasionally consult on new medicines for pharmaceutical companies. None of these interests have any relation to the Montreal Protocol, TEAP, MCTOC, or any Task Force.
• Government advice and other policy development: I am on an advisory panel on the phase down of HFC inhalers for UK NHS Sustainability, and am Clinical Sustainability Lead for the Manchester University NHS Foundation Trust and associated hospitals.  No other relevant activity
• Paid research activities, fellowships or grants: None relevant
• Other interests: None relevant

5) The source of funding for my participation in the work of TEAP is Manchester University NHS Foundation NHS Trust, which allows me to take leave and provides travel support to attend meetings

6)   Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines. 

7)   I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.

8)   I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.

9)   I understand that this DOI will expire no later than one year after I have signed it.

Signed: Ashley Woodcock

Date: Jan 24 2020